868
Views
6
CrossRef citations to date
0
Altmetric
Author's View

Breaking bad habits: Targeting MDSCs to alleviate immunosuppression in prostate cancer

&
Article: e1078060 | Received 22 Jul 2015, Accepted 22 Jul 2015, Published online: 26 Feb 2016

References

  • Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
  • Vuk-Pavlovic S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, Dietz AB. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate 2010 Mar 1; 70(4):443-55; PMID:19902470; http://dx.doi.org/10.1002/pros.21078
  • Hossain DM, Pal SK, Moreira DFD, Duttagupta P, Zhang Q, Won H, Jones J, D'Apuzzo M, Forman S, Kortylewski M. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients. Clin Cancer Res 2015; 21(16):3771-82; PMID:25967142; http://dx.doi.org/10.1158/1078-0432.CCR-14-3145
  • Zoglmeier C, Bauer H, Norenberg D, Wedekind G, Bittner P, Sandholzer N, Rapp M, Anz D, Endres S, Bourquin C. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res 2011; 17:1765-75; PMID:21233400; http://dx.doi.org/10.1158/1078-0432.CCR-10-2672
  • Krieg AM. CpG still rocks! Update on an accidental drug. Nucleic acid therapeutics 2012; 22:77-89; PMID:22352814; http://dx.doi.org/10.1089/nat.2012.0340
  • Kortylewski M, Kujawski M, Herrmann A, Yang C, Wang L, Liu Y, Salcedo R, Yu H. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. Cancer Res 2009; 69:2497-505; PMID:19258507; http://dx.doi.org/10.1158/0008-5472.CAN-08-3031
  • Gao C, Kozlowska A, Nechaev S, Li H, Zhang Q, Hossain DM, Kowolik CM, Chu P, Swiderski P, Diamond DJ et al. TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy. Cancer Res 2013; 73:7211-21; PMID:24154870; http://dx.doi.org/10.1158/0008-5472.CAN-13-1314
  • Kortylewski M, Swiderski P, Herrmann A, Wang L, Kowolik C, Kujawski M, Lee H, Scuto A, Liu Y, Yang C et al. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat Biotechnol 2009; 27:925-32; PMID:19749770; http://dx.doi.org/10.1038/nbt.1564
  • Zhang Q, Hossain DM, Nechaev S, Kozlowska A, Zhang W, Liu Y, Kowolik CM, Swiderski P, Rossi JJ, Forman S et al. TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo. Blood 2013; 121:1304-15; PMID:23287859; http://dx.doi.org/10.1182/blood-2012-07-442590
  • Moreira D, Zhang Q, Hossain DM, Nechaev S, Li H, Kowolik CM, D'Apuzzo M, Forman S, Jones J, Pal SK et al. TLR9 signaling through NF-kappaB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells. Oncotarget 2015; 6(19):17302-13; PMID:26046794; http://dx.doi.org/10.18632/oncotarget.4029

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.